Biomedical Engineering Reference
In-Depth Information
Lu J, Liong M, Fink ZI, F. Tamanoi F (2007) Mesoporous silica nanoparticles as a delivery system
for hydrophobic anticancer drug, Small 3:1341-1346
Lu J, Liong M, Li Z, Zink J, Tamanoi F (2010) Biocompatibility, biodistribution, and drug-
delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. Small.
6:1794-1805
Mailaender V, Landfester K (2009) Interaction of Nanoparticles with Cells. Biomacromolecules
10:2379-2400
Mao Z, Wan L, Hu L, Ma L, Gao C (2010) Tat peptide mediated cellular uptake of SiO
2
submicron
particles. Colloids Surf B 75:432-440
Mellaerts R, Mols R, Jammaer JAG, Aerts CA, Annaert P, Humbeeck JV, Van den Mooter G,
Augustijns P, Martens JA (2008) Increasing the oral bioavailability of the poorly water soluble
drug itraconazole with ordered mesoporous silica, Eur J Pharm Biopharm 69:223-230
Nishimori H, Kondoh M, Isoda K, Tsunoda S, Tsutsumi Y, Yagi K (2009) Histological analysis
of 70 nm silica particles-induced chronic toxicity in mice. Eur J Pharm Biopharm
72:626-629
Park YH, Kim JN, Jepong SH et al (2010) Assessment of dermal toxicity of nanosilica using
culture keratinocytes, a human skin equivalent model and an in vivo model. Toxicol
267:178-181
Radhakrishnan B, Ranjan R, Brittain WJ (2006) Surface initiated polymerizations from silica
nanoparticles. Soft Matter 2:386-396
Radu DR, Lai CY, Jeftinija K, Rowe EW, Jeftinija S, Lin VSY (2004) A polyamidoamine
dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent, J Am Chem
Soc 126:13216-13217
Rao KS, El-Hami K, Kodaki T, Matsushige K (2005) A novel method for the synthesis of silica
nanoparticles. J Colloid Interf Sci 289:125-131
Rimer JD, Trofymluk O, Navrotsky A, Lobo RF, Vlachos DG (2007) Kinetic and thermodynamic
studies of silica nanoparticle dissolution. Chem Mater 19:4189-4197
Rosenholm J, Meinander A, Peuhu E, Niemi R, Eriksson J, Sahlgren C, Lindén M (2009)
Targeting of porous hybrid silica nanoparticles to cancer cells. ACS Nano 3:197-206
Rosenholm JM, Sahlgren C, Linden M (2010) Towards multifunctional, targeted drug delivery
systems using mesoporous silica nanoparticles- opportunities & challenges. Nanoscale
2:1870-1883
Santra S (2004) TAT conjugated, FITC doped silica nanoparticles for bioimaging applications,
Chem Commun 24:2810-2811
Sauer A, Schlossbauer A, Ruthardt N, Cauda V, Bein T, Bräuchle C (2010) Role of Endosomal
Escape for Disulfide-Based Drug Delivery from Colloidal Mesoporous Silica Evaluated by
Live-Cell Imaging. Nano Lett 10:3684-3691
Sertchook H, Elimelech H, Makarov C, Khalfin R, Cohen Y, Shuster M, Babonneau F, Avnir D
(2007) Composite particles of polyethylene@silica. J Am Chem Soc 129:98-108.
Sola R, Boj M, Hernandez-Felix S, Camprubi M (2009) Silica in oral drugs as a possible sarcoidosis-
inducing antigen. Lancet 373:1943-1944
Slowing II, Trewyn BG, Lin VSY (2006) Effect of surface functionalisation of MCM-41-type
mesoporous silica nanoparticles on the endocytosis by human cancer cells. J Am Chem Soc
128:14792-14793
Slowing II, Vivero-Escoto JL, Wu CW, Lin VSY (2008) Mesoporous silica nanoparticles as con-
trolled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev 60:
1278-1288
Soler Illia GJ, Sanchez C, Lebeau B, Patarin J (2002) Chemical strategies to design textured
materials: from microporous and mesoporous oxides to nanonetworks and hierarchical struc-
tures. Chem Rev 102:4093-4138
Souris JS, Lee CH, Cheng SH, Chen CT, Yang CS, Ho JA, Mou CY, Lo LW (2010) Surface
charge-mediated rapid hepatobiliary excretion of mesoporous silica nanoparticles. Biomaterials
31:5564-5574
Search WWH ::
Custom Search